Open‐Label Phase 1 Futility Studies of Salsalate and Young Plasma in Progressive Supranuclear Palsy-Reference-Cited by-同舟云学术

Open‐Label Phase 1 Futility Studies of Salsalate and Young Plasma in Progressive Supranuclear Palsy

Published:2020-04-10 Issue:4 Volume:7 Page:440-447
ISSN:2330-1619
Container-title:Movement Disorders Clinical Practice
language:en
Short-container-title:Mov Disord Clin Pract

Author:

VandeVrede Lawren¹^ORCID,Dale Marian L.²,Fields Scott³,Frank Megan¹,Hare Emma¹,Heuer Hilary W.¹,Keith Kellie²,Koestler Mary¹,Ljubenkov Peter A.¹,McDermott Dana¹,Ohanesian Noelle¹,Richards Jennifer¹,Rojas Julio C.¹,Thijssen Elisabeth H.¹⁴,Walsh Christine¹,Wang Ping¹,Wolf Amy¹,Quinn Joseph F.²,Tsai Richard¹,Boxer Adam L.¹

Affiliation:

1. Memory and Aging Center, Department of Neurology University of California San Francisco California USA

2. OHSU Parkinson Center and Movement Disorder Program, Department of Neurology Oregon Health and Science University Portland, Oregon USA

3. Department of Pharmaceutical Services University of California San Francisco California USA

4. Neurochemistry Laboratory, Department of Clinical Chemistry VU University Medical Center Amsterdam The Netherlands

Funder

Korea National Institute of Health

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mdc3.12940

Reference33 articles.

1. Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches

2. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

3. Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes

4. Therapeutic options for Progressive Supranuclear Palsy including investigational drugs

5. CoQ10 in progressive supranuclear palsy

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies;Translational Neurodegeneration;2024-08-06

2. Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review;Neurology and Therapy;2024-05-14

3. Healthy blood, healthy brain: a window into understanding and treating neurodegenerative diseases;Journal of Neurology;2024-04-12

4. The six brain‐specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes;Alzheimer's & Dementia;2024-03-31

5. Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach;International Journal of Molecular Sciences;2023-12-23